Tag: http://www.PetLifePharma.com

Feature Box

PetLife Pharmaceuticals Continues Execution of its Vitalzul TM Business Plan with start of Proof of Concept studies; Provides Updates

Hancock, MD, Sept. 14, 2016 (GLOBE NEWSWIRE) — Hancock, MD – PetLife Pharmaceuticals, Inc. (OTC QB: PTLFD) (the “Company”), a developer of Vitalzulā„¢, a new generation of high potency veterinary cancer medications and nutraceuticals for pets, announces plans to begin its Proof of Concept study as part of its pre-INAD (Investigational New Animal Drug) program. The study will be undertaken under contract by InnoVision Therapeutics. Proof of Concept studies are an early stage of clinical drug development when a compound has shown potential in animal models and early safety testing. These small-scale studies are designed to detect a signal that